| 000 | 01902 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250516185712.0 | ||
| 264 | 0 | _c20140915 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1099-1557 | ||
| 024 | 7 |
_a10.1002/pds.3552 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTon, Thanh G N | |
| 245 | 0 | 0 |
_aEnhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study. _h[electronic resource] |
| 260 |
_bPharmacoepidemiology and drug safety _cFeb 2014 |
||
| 300 |
_a119-27 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDatabases, Factual _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedicare |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnosis |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSmoking _xepidemiology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aBiggs, Mary Lou | |
| 700 | 1 | _aComer, Diane | |
| 700 | 1 | _aCurtis, Lesley | |
| 700 | 1 | _aHu, Shu-Ching | |
| 700 | 1 | _aThacker, Evan L | |
| 700 | 1 | _aSearles Nielsen, Susan | |
| 700 | 1 | _aDelaney, Joseph A | |
| 700 | 1 | _aLandsittel, Douglas | |
| 700 | 1 | _aLongstreth, William T | |
| 700 | 1 | _aCheckoway, Harvey | |
| 700 | 1 | _aJain, Samay | |
| 773 | 0 |
_tPharmacoepidemiology and drug safety _gvol. 23 _gno. 2 _gp. 119-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pds.3552 _zAvailable from publisher's website |
| 999 |
_c23385219 _d23385219 |
||